Abstract:Objective To construct prokaryotic expression vector of BC047440 gene to express and purify its recombinant protein. Methods The total RNA was extracted from HepG2 cells. The BC047440 gene fragment was amplified from the total RNA by RT-PCR. The resulting product was cloned into pMD19-T vector and sequenced. Then the confirmed BC047440 cDNA was cloned into plasmid pET-28a( + ) and transformed into E. coli BL21 where it was induced to express proteins by i-sopropyl-1-thio-b-Dgalactopyranoside (IPTG). The expression of protein was analyzed through SDS-PAGE cells induced for 3 h by IPTG harvesting. Then it was sonicated briefly and the proteins were purified through affinity chromatography. Results The target sequences were specifically amplified through RT-PCR, cloned into pMD19-T vector, and then transformed into E. coli DH5a. Five white colonies were selected and cut by BamHI and EcoRl separately. The plasmids of two white colonies showed positive results and was sequenced, demonstrating to be the same as that of BC047440 gene in GenBank. Then BC047440 cDNA was cut down from pMD19-T, ligated into the vector pET-28a( + ) and then transformed into E. coli BL21. After an overnight incubation, seven white colonies were picked and showed positive results after being digested by both BamHI and EcoRI. After IPTG induction of one positive colony, a new protein band about Mr 23000 showed on SDS-PAGE. The percentage of expressed product over total bacterial proteins after 4 hours of induction was 22. 3%. After affinity chromatography, SDS-PAGE showed only one clear band existed in 50 mmol/L or 125 mmol/L imidizone elution. Conclusion The prokaryotic expression vector of BC047440 gene has been successfully constructed. Meanwhile, purified recombinant proteins are obtained through affinity chromatography, laying foundation for further study of its clinical use.

Construction of a Shrna Eukaryotic Expression Vector of Dual Promoters

[Construction of Shrna Expression Vector Silencing Kir6.2 Gene and to Study Its Influence on the Proliferation and Invasion of HepG2 Cells].

Constructing Prokaryotic Vector of BC047440 Gene Expression and Purification of Its Recombinant Protein

Construction and identification of shRNA eukaryotic expression vectors targeting to prohibitin gene

Construction of the eukaryotic expression plasmid compatible with the detection system of shuttle plasmid pZ189

TALEN/CRISPR-mediated Engineering of a Promoterless Anti-Viral RNAi Hairpin into an Endogenous Mirna Locus

Development of a species-specific RNA polymerase I-based shRNA expression vector

A novel approach for the construction of multiple shRNA expression vectors.

Cloning of SARS-CoV-S Gene and Construction of Its Short Interfering RNAs Expression Vector

Construction of Human Tissue Factor RNA Interference Eukaryotic Expression Vector

Construction and Identification of Recombinant TPH2-targeted Small Interfering RNA Expression Vector

Generation of three kinds of promoter-shRNA expression cassettes and their application in screening of efficient siRNA

Construction of recombinant vectors introducing ubiquitous expression or tissue-specific expression in Caenorhabditis elegans

Construction of STAT3 shRNA eukaryotic expression vector

Construction of a New High Efficient Prokaryotic Expression Vector

Construction and Identification of Lentiviral Vetors Expressing Shrna of Rat MeCP2 Gene

Construction of Recombinant Lentiviral Vector Containing Shrna for Human Neuropilin-1 Gene

Expression of shRNA From a Tissue-specific pol II Promoter Is an Effective and Safe RNAi Therapeutic

Construction and Identification of Eukaryotic Expression Vector Bearing Mouse Ghrelin Receptor

Design and cloning strategies for constructing shRNA expression vectors

Construction and appraisal of recombinant adeno-associated virus vector for expressing shRNA targeting CIP2A mRNA